Clin Exp Otorhinolaryngol.  2022 Nov;15(4):299-309. 10.21053/ceo.2022.01382.

Precision Medicine Approach to Cochlear Implantation

• Kim Y
• Choi BY

• KMID: 2536528
• DOI: http://doi.org/10.21053/ceo.2022.01382

Abstract

In the early days of cochlear implantation (CI) surgery, when the types of electrodes were limited and the etiology of sensorineural hearing loss (SNHL) was not well understood, the one-size-fits-all approach to CI held true, as in all other fields. However, in the era of personalized medicine, there have been attempts to associate CI performance with the etiology of SNHL and to establish customized surgical techniques that can maximize performance according to individual cochlear dimensions. Personalized genomic-driven assessments of CI candidates and a better understanding of genotype-phenotype correlations could provide clinically applicable diagnostic and prognostic information about questions such as who, how, and when to implant. Rigorous and strategic imaging assessments also provide better insights into the anatomic etiology of SNHL and cochlear dimensions, leading to individualized surgical techniques to augment CI outcomes. Furthermore, the precision medicine approach to CI is not necessarily limited to preoperative planning, but can be extended to either intraoperative electrode positioning or even the timing of the initial switch-on. In this review, we discuss the implications of personalized diagnoses (both genetic and nongenetic) on the planning and performance of CI in patients with prelingual and postlingual SNHL.

Reference

1. Tomblin JB, Spencer L, Flock S, Tyler R, Gantz B. A comparison of language achievement in children with cochlear implants and children using hearing aids. J Speech Lang Hear Res. 1999; Apr. 42(2):497–509.

2. Blamey P, Artieres F, Baskent D, Bergeron F, Beynon A, Burke E, et al. Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants: an update with 2251 patients. Audiol Neurootol. 2013; 18(1):36–47.

3. Moberly AC, Bates C, Harris MS, Pisoni DB. The enigma of poor performance by adults with cochlear implants. Otol Neurotol. 2016; Dec. 37(10):1522–8.

4. Archbold SM, Nikolopoulos TP, Lloyd-Richmond H. Long-term use of cochlear implant systems in paediatric recipients and factors contributing to non-use. Cochlear Implants Int. 2009; Mar. 10(1):25–40.

5. Raine CH, Summerfield Q, Strachan DR, Martin JM, Totten C. The cost and analysis of nonuse of cochlear implants. Otol Neurotol. 2008; Feb. 29(2):221–4.

6. Lee CY, Lin PH, Tsai CY, Chiang YT, Chiou HP, Chiang KY, et al. Comprehensive etiologic analyses in pediatric cochlear implantees and the clinical implications. Biomedicines. 2022; Jul. 10(8):1846.

7. Nishio SY, Moteki H, Miyagawa M, Yamasoba T, Kashio A, Iwasaki S, et al. Etiology of hearing loss affects auditory skill development and vocabulary development in pediatric cochlear implantation cases. Acta Otolaryngol. 2022; Mar-Apr. 142(3-4):308–15.

8. Lee SY, Shim YJ, Han JH, Song JJ, Koo JW, Oh SH, et al. The molecular etiology of deafness and auditory performance in the postlingually deafened cochlear implantees. Sci Rep. 2020; Apr. 10(1):5768.

9. Rak K, Ilgen L, Taeger J, Schendzielorz P, Voelker J, Kaulitz S, et al. Influence of cochlear parameters on the current practice in cochlear implantation: development of a concept for personalized medicine. HNO. 2021; Jan. 69(Suppl 1):24–30.

10. Lee SY, Bae YJ, Carandang M, Kim Y, Han JH, Huh G, et al. Influence of cochlear parameters on the current practice in cochlear implantation: development of a concept for personalized medicine. Ear Hear. 2021; Mar/Apr. 42(2):323–33.

11. Miyagawa M, Nishio SY, Ikeda T, Fukushima K, Usami S. Massively parallel DNA sequencing successfully identifies new causative mutations in deafness genes in patients with cochlear implantation and EAS. PLoS One. 2013; Oct. 8(10):e75793.

12. Park JH, Kim AR, Han JH, Kim SD, Kim SH, Koo JW, et al. Outcome of cochlear implantation in prelingually deafened children according to molecular genetic etiology. Ear Hear. 2017; Sep/Oct. 38(5):e316–24.

13. Wu CC, Lin YH, Liu TC, Lin KN, Yang WS, Hsu CJ, et al. Identifying children with poor cochlear implantation outcomes using massively parallel sequencing. Medicine (Baltimore). 2015; Jul. 94(27):e1073.

14. Wu CM, Ko HC, Tsou YT, Lin YH, Lin JL, Chen CK, et al. Long-term cochlear implant outcomes in children with GJB2 and SLC26A4 mutations. PLoS One. 2015; Sep. 10(9):e0138575.

15. Rodriguez-Ballesteros M, del Castillo FJ, Martin Y, Moreno-Pelayo MA, Morera C, Prieto F, et al. Auditory neuropathy in patients carrying mutations in the otoferlin gene (OTOF). Hum Mutat. 2003; Dec. 22(6):451–6.

16. Sharma A, Cardon G. Cortical development and neuroplasticity in auditory neuropathy spectrum disorder. Hear Res. 2015; Dec. 330(Pt B):221–32.

17. Lee SY, Han JH, Song HK, Kim NJ, Yi N, Kyong JS, et al. Central auditory maturation and behavioral outcomes after cochlear implantation in prelingual auditory neuropathy spectrum disorder related to OTOF variants (DFNB9): lessons from pilot study. PLoS One. 2021; Jun. 16(6):e0252717.

18. Liu Y, Dong R, Li Y, Xu T, Li Y, Chen X, et al. Effect of age at cochlear implantation on auditory and speech development of children with auditory neuropathy spectrum disorder. Auris Nasus Larynx. 2014; Dec. 41(6):502–6.

19. Kim BJ, Jang JH, Han JH, Park HR, Oh DY, Lee S, et al. Mutational and phenotypic spectrum of OTOF-related auditory neuropathy in Koreans: eliciting reciprocal interaction between bench and clinics. J Transl Med. 2018; Nov. 16(1):330.

20. Philips B, Maes LK, Keppler H, Dhooge I. Cochlear implants in children deafened by congenital cytomegalovirus and matched Connexin 26 peers. Int J Pediatr Otorhinolaryngol. 2014; Mar. 78(3):410–5.

21. Lee DJ, Lustig L, Sampson M, Chinnici J, Niparko JK. Effects of cytomegalovirus (CMV) related deafness on pediatric cochlear implant outcomes. Otolaryngol Head Neck Surg. 2005; Dec. 133(6):900–5.

22. Laccourreye L, Ettienne V, Prang I, Couloigner V, Garabedian EN, Loundon N. Speech perception, production and intelligibility in French-speaking children with profound hearing loss and early cochlear implantation after congenital cytomegalovirus infection. Eur Ann Otorhinolaryngol Head Neck Dis. 2015; Dec. 132(6):317–20.

23. Han JJ, Bae YJ, Song SK, Song JJ, Koo JW, Lee JH, et al. Prediction of the outcome of cochlear implantation in the patients with congenital cytomegalovirus infection based on magnetic resonance imaging characteristics. J Clin Med. 2019; Jan. 8(2):136.

24. Vlastarakos PV, Nikolopoulos TP, Pappas S, Buchanan MA, Bewick J, Kandiloros D. Cochlear implantation update: contemporary preoperative imaging and future prospects: the dual modality approach as a standard of care. Expert Rev Med Devices. 2010; Jul. 7(4):555–67.

25. Yousef M, Mesallam TA, Garadat SN, Almasaad A, Alzhrani F, Alsanosi A, et al. Audiologic outcome of cochlear implantation in children with cochlear nerve deficiency. Otol Neurotol. 2021; Jan. 42(1):38–46.

26. Valero J, Blaser S, Papsin BC, James AL, Gordon KA. Electrophysiologic and behavioral outcomes of cochlear implantation in children with auditory nerve hypoplasia. Ear Hear. 2012; Jan-Feb. 33(1):3–18.

27. Incerti PV, Ching TY, Hou S, Van Buynder P, Flynn C, Cowan R. Programming characteristics of cochlear implants in children: effects of aetiology and age at implantation. Int J Audiol. 2018; May. 57(sup2):S27–40.

28. Sunwoo W, Jeon HW, Choi BY. Effect of initial switch-on within 24 hours of cochlear implantation using slim modiolar electrodes. Sci Rep. 2021; Nov. 11(1):22809.

29. Kim Y, Kim Y, Kim YS, Lee SY, Choi BY. Tight modiolar proximity and feasibility of slim modiolar cochlear implant electrode array insertion in diverse etiologies of hearing loss. Eur Arch Otorhinolaryngol. 2022; Aug. 279(8):3899–909.

30. Lee SY, Choi BY. Potential implications of slim modiolar electrodes for severely malformed cochleae: a comparison with the straight array with circumferential electrodes. Clin Exp Otorhinolaryngol. 2021; Aug. 14(3):287–94.

31. Bae SH, Choi J, Choi JY. Cochlear implants for patients with common cavity deformities and the impact of electrode positioning. Clin Exp Otorhinolaryngol. 2022; Feb. 15(1):77–83.

32. Shearer AE, Eppsteiner RW, Frees K, Tejani V, Sloan-Heggen CM, Brown C, et al. Genetic variants in the peripheral auditory system significantly affect adult cochlear implant performance. Hear Res. 2017; May. 348:138–42.

33. Vermeire K, Brokx JP, Wuyts FL, Cochet E, Hofkens A, De Bodt M, et al. Good speech recognition and quality-of-life scores after cochlear implantation in patients with DFNA9. Otol Neurotol. 2006; Jan. 27(1):44–9.

34. Pecci A, Verver EJ, Schlegel N, Canzi P, Boccio CM, Platokouki H, et al. Cochlear implantation is safe and effective in patients with MYH9-related disease. Orphanet J Rare Dis. 2014; Jun. 9:100.

35. Eppsteiner RW, Shearer AE, Hildebrand MS, Deluca AP, Ji H, Dunn CC, et al. Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis. Hear Res. 2012; Oct. 292(1-2):51–8.

36. Miyagawa M, Nishio SY, Sakurai Y, Hattori M, Tsukada K, Moteki H, et al. The patients associated with TMPRSS3 mutations are good candidates for electric acoustic stimulation. Ann Otol Rhinol Laryngol. 2015; May. 124 Suppl 1:193S–204S.

37. Tolisano AM, Baumgart B, Whitson J, Kutz JW. Cochlear implantation in patients with neurofibromatosis type 2. Otol Neurotol. 2019; Apr. 40(4):e381–5.

38. Kim TB, Isaacson B, Sivakumaran TA, Starr A, Keats BJ, Lesperance MM. A gene responsible for autosomal dominant auditory neuropathy (AUNA1) maps to 13q14-21. J Med Genet. 2004; Nov. 41(11):872–6.

39. Ruel J, Emery S, Nouvian R, Bersot T, Amilhon B, Van Rybroek JM, et al. Impairment of SLC17A8 encoding vesicular glutamate transporter-3, VGLUT3, underlies nonsyndromic deafness DFNA25 and inner hair cell dysfunction in null mice. Am J Hum Genet. 2008; Aug. 83(2):278–92.

40. Chen DY, Liu XF, Lin XJ, Zhang D, Chai YC, Yu DH, et al. A dominant variant in DMXL2 is linked to nonsyndromic hearing loss. Genet Med. 2017; May. 19(5):553–8.

41. Jang MW, Oh DY, Yi E, Liu X, Ling J, Kim N, et al. Nonsense TMEM43 variant leads to disruption of connexin-linked function and autosomal dominant auditory neuropathy spectrum disorder. Proc Natl Acad Sci U S A. 2021; Jun. 118(22):e2019681118.

42. Han KH, Oh DY, Lee S, Lee C, Han JH, Kim MY, et al. ATP1A3 mutations can cause progressive auditory neuropathy: a new gene of auditory synaptopathy. Sci Rep. 2017; Nov. 7(1):16504.

43. Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, et al. OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation. Brain. 2015; Mar. 138(Pt 3):563–76.

44. Kim BJ, Kim YH, Han JH, Lee SY, Carandang M, Lee DH, et al. Outcome of cochlear implantation in NLRP3-related autoinflammatory inner ear disorders. Otol Neurotol. 2021; Feb. 42(2):e168–71.

45. Holder JT, Morrel W, Rivas A, Labadie RF, Gifford RH. Cochlear implantation and electric acoustic stimulation in children with TMPRSS3 genetic mutation. Otol Neurotol. 2021; Mar. 42(3):396–401.

46. Kim Y, Han JH, Yoo HS, Choi BY. Molecular aetiology of ski-slope hearing loss and audiological course of cochlear implantees. Eur Arch Otorhinolaryngol. 2022; Oct. 279(10):4871–82.

47. Yoshimura H, Moteki H, Nishio SY, Miyajima H, Miyagawa M, Usami SI. Genetic testing has the potential to impact hearing preservation following cochlear implantation. Acta Otolaryngol. 2020; Jun. 140(6):438–44.

48. Ramos de Miguel A, Durmo I, Falcon Gonzalez JC, Borkoski Barreiro S, Ramos Macias A. Evaluation of intracochlear position of a slim modiolar electrode array, by using different radiological analyses. Otol Neurotol. 2019; Jun. 40(5S Suppl 1):S10–7.

49. Riemann C, Sudhoff H, Todt I. The pull-back technique for the 532 slim modiolar electrode. Biomed Res Int. 2019; May. 2019:6917084.

50. Shearer AE, DeLuca AP, Hildebrand MS, Taylor KR, Gurrola J 2nd, Scherer S, et al. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci U S A. 2010; Dec. 107(49):21104–9.

51. Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A, et al. Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol. 2011; Sep. 14;12(9):R89.

52. Black J, Hickson L, Black B, Perry C. Prognostic indicators in paediatric cochlear implant surgery: a systematic literature review. Cochlear Implants Int. 2011; May. 12(2):67–93.

53. Park JH, Kim NK, Kim AR, Rhee J, Oh SH, Koo JW, et al. Exploration of molecular genetic etiology for Korean cochlear implantees with severe to profound hearing loss and its implication. Orphanet J Rare Dis. 2014; Nov. 9:167.

54. Wu CC, Lee YC, Chen PJ, Hsu CJ. Predominance of genetic diagnosis and imaging results as predictors in determining the speech perception performance outcome after cochlear implantation in children. Arch Pediatr Adolesc Med. 2008; Mar. 162(3):269–76.

55. Yan YJ, Li Y, Yang T, Huang Q, Wu H. The effect of GJB2 and SLC26A4 gene mutations on rehabilitative outcomes in pediatric cochlear implant patients. Eur Arch Otorhinolaryngol. 2013; Nov. 270(11):2865–70.

56. Yoshida H, Takahashi H, Kanda Y, Usami S. Long term speech perception after cochlear implant in pediatric patients with GJB2 mutations. Auris Nasus Larynx. 2013; Oct. 40(5):435–9.

57. Delmaghani S, Defourny J, Aghaie A, Beurg M, Dulon D, Thelen N, et al. Hypervulnerability to sound exposure through impaired adaptive proliferation of peroxisomes. Cell. 2015; Nov. 163(4):894–906.

58. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007; Jul-Aug. 17(4):253–76.

59. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013; Jan. 26(1):86–102.

60. Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006; Feb. 35(2):226–31.

61. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA. 1986; Oct. 256(14):1904–8.

62. Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014; Nov. 134(5):972–82.

63. Goderis J, Keymeulen A, Smets K, Van Hoecke H, De Leenheer E, Boudewyns A, et al. Hearing in children with congenital cytomegalovirus infection: results of a longitudinal study. J Pediatr. 2016; May. 172:110–5. e2.

64. Medearis DN. Viral infections during pregnancy and abnormal human development. Am J Obstet Gynecol. 1964; Dec. 90(7):1140–8.

65. Kim BJ, Han JJ, Shin SH, Kim HS, Yang HR, Choi EH, et al. Characterization of detailed audiological features of cytomegalovirus infection: a composite cohort study from groups with distinct demographics. Biomed Res Int. 2018; Aug. 2018:7087586.

66. Sohn YM, Park KI, Lee C, Han DG, Lee WY. Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity. J Korean Med Sci. 1992; Mar. 7(1):47–51.

67. Barkai G, Ari-Even Roth D, Barzilai A, Tepperberg-Oikawa M, Mendelson E, Hildesheimer M, et al. Universal neonatal cytomegalovirus screening using saliva: report of clinical experience. J Clin Virol. 2014; Aug. 60(4):361–6.

68. Ramirez Inscoe JM, Nikolopoulos TP. Cochlear implantation in children deafened by cytomegalovirus: speech perception and speech intelligibility outcomes. Otol Neurotol. 2004; Jul. 25(4):479–82.

69. Iwasaki S, Nakanishi H, Misawa K, Tanigawa T, Mizuta K. Cochlear implant in children with asymptomatic congenital cytomegalovirus infection. Audiol Neurootol. 2009; 14(3):146–52.

70. Matsui T, Ogawa H, Yamada N, Baba Y, Suzuki Y, Nomoto M, et al. Outcome of cochlear implantation in children with congenital cytomegalovirus infection or GJB2 mutation. Acta Otolaryngol. 2012; Jun. 132(6):597–602.

71. Ciorba A, Bovo R, Trevisi P, Bianchini C, Arboretti R, Martini A. Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infection. Eur Arch Otorhinolaryngol. 2009; Oct. 266(10):1539–46.

72. Malik V, Bruce IA, Broomfield SJ, Henderson L, Green KM, Ramsden RT. Outcome of cochlear implantation in asymptomatic congenital cytomegalovirus deafened children. Laryngoscope. 2011; Aug. 121(8):1780–4.

73. Viccaro M, Filipo R, Bosco E, Nicastri M, Mancini P. Long-term follow-up of implanted children with cytomegalovirus-related deafness. Audiol Neurootol. 2012; Oct. 17(6):395–9.

74. Casselman JW, Offeciers FE, Govaerts PJ, Kuhweide R, Geldof H, Somers T, et al. Aplasia and hypoplasia of the vestibulocochlear nerve: diagnosis with MR imaging. Radiology. 1997; Mar. 202(3):773–81.

75. Glastonbury CM, Davidson HC, Harnsberger HR, Butler J, Kertesz TR, Shelton C. Imaging findings of cochlear nerve deficiency. AJNR Am J Neuroradiol. 2002; Apr. 23(4):635–43.

76. McClay JE, Booth TN, Parry DA, Johnson R, Roland P. Evaluation of pediatric sensorineural hearing loss with magnetic resonance imaging. Arch Otolaryngol Head Neck Surg. 2008; Sep. 134(9):945–52.

77. Birman CS, Powell HR, Gibson WP, Elliott EJ. Cochlear implant outcomes in cochlea nerve aplasia and hypoplasia. Otol Neurotol. 2016; Jun. 37(5):438–45.

78. Ozdogmus O, Sezen O, Kubilay U, Saka E, Duman U, San T, et al. Connections between the facial, vestibular and cochlear nerve bundles within the internal auditory canal. J Anat. 2004; Jul. 205(1):65–75.

79. Thai-Van H, Fraysse B, Berry I, Berges C, Deguine O, Honegger A, et al. Functional magnetic resonance imaging may avoid misdiagnosis of cochleovestibular nerve aplasia in congenital deafness. Am J Otol. 2000; Sep. 21(5):663–70.

80. Acker T, Mathur NN, Savy L, Graham JM. Is there a functioning vestibulocochlear nerve? Cochlear implantation in a child with symmetrical auditory findings but asymmetric imaging. Int J Pediatr Otorhinolaryngol. 2001; Feb. 57(2):171–6.

81. Buchman CA, Teagle HF, Roush PA, Park LR, Hatch D, Woodard J, et al. Cochlear implantation in children with labyrinthine anomalies and cochlear nerve deficiency: implications for auditory brainstem implantation. Laryngoscope. 2011; Sep. 121(9):1979–88.

82. Young NM, Kim FM, Ryan ME, Tournis E, Yaras S. Pediatric cochlear implantation of children with eighth nerve deficiency. Int J Pediatr Otorhinolaryngol. 2012; Oct. 76(10):1442–8.

83. Shelton C, Luxford WM, Tonokawa LL, Lo WW, House WF. The narrow internal auditory canal in children: a contraindication to cochlear implants. Otolaryngol Head Neck Surg. 1989; Mar. 100(3):227–31.

84. Brotto D, Avato I, Lovo E, Muraro E, Bovo R, Trevisi P, et al. Epidemiologic, imaging, audiologic, clinical, surgical, and prognostic issues in common cavity deformity: a narrative review. JAMA Otolaryngol Head Neck Surg. 2019; Jan. 145(1):72–8.

85. Kim BJ, Choi BY. How to maximize the outcomes of cochlear implantation in common cavity and cochlear aplasia with dilated vestibule, the most severe inner ear anomalies. Clin Exp Otorhinolaryngol. 2022; Feb. 15(1):3–4.

86. Alhabib SF. Audiological and speech performance after cochlear implantation in cochlear aplasia deformity. Cureus. 2021; Jul. 13(7):e16654.

87. Jeong SW, Kim LS. Cochlear implantation in children with cochlear aplasia. Acta Otolaryngol. 2012; Sep. 132(9):910–5.

88. Graham JM, Phelps PD, Michaels L. Congenital malformations of the ear and cochlear implantation in children: review and temporal bone report of common cavity. J Laryngol Otol Suppl. 2000; Mar. 114(S25):1–14.

89. Yamazaki H, Naito Y, Fujiwara K, Moroto S, Yamamoto R, Yamazaki T, et al. Electrically evoked auditory brainstem response-based evaluation of the spatial distribution of auditory neuronal tissue in common cavity deformities. Otol Neurotol. 2014; Sep. 35(8):1394–402.

90. Wei X, Zhang H, Lu S, Yang M, Chen B, Chen J, et al. Application of multiplanar volume reconstruction technique for the assessment of electrode location and analysis of the correlation to cochlear programming and performance in common cavity deformity. Front Neurol. 2022; Jan. 12:783225.

91. Miyagawa M, Nishio SY, Usami S. A comprehensive study on the etiology of patients receiving cochlear implantation with special emphasis on genetic epidemiology. Otol Neurotol. 2016; Feb. 37(2):e126–34.

92. Michalski N, Petit C. Genes involved in the development and physiology of both the peripheral and central auditory systems. Annu Rev Neurosci. 2019; Jul. 42:67–86.

93. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004; Mar. 20(3):319–25.

94. Kim YH, Kim BJ, Han J, Choi BY, Lee S. Long-term efficacy of anakinra in cryopyrin-associated periodic syndrome: focus on destructive arthropathy. J Clin Immunol. 2021; Nov. 41(8):1936–9.

95. Kim BJ, Kim YH, Lee S, Han JH, Lee SY, Seong J, et al. Otological aspects of NLRP3-related autoinflammatory disorder focusing on the responsiveness to anakinra. Rheumatology (Oxford). 2021; Mar. 60(3):1523–32.

96. Choi BY, Park G, Gim J, Kim AR, Kim BJ, Kim HS, et al. Diagnostic application of targeted resequencing for familial nonsyndromic hearing loss. PLoS One. 2013; Aug. 8(8):e68692.

97. Shearer AE, Hildebrand MS, Smith RJ. Hereditary hearing loss and deafness overview. Seattle (WA): University of Washington, Seattle;2017.

98. Roland JT, Gantz BJ, Waltzman SB, Parkinson AJ. Long-term outcomes of cochlear implantation in patients with high-frequency hearing loss. Laryngoscope. 2018; Aug. 128(8):1939–45.

99. Shew MA, Walia A, Durakovic N, Valenzuela C, Wick CC, McJunkin JL, et al. Long-term hearing preservation and speech perception performance outcomes with the slim modiolar electrode. Otol Neurotol. 2021; Dec. 42(10):e1486–93.

100. Haber K, Neagu A, Konopka W, Amernik K, Gheorghe DC, Drela M, et al. The influence of slim modiolar electrode on residual hearing in pediatric patients. Eur Arch Otorhinolaryngol. 2021; Aug. 278(8):2723–32.

101. O’Connell BP, Hunter JB, Haynes DS, Holder JT, Dedmon MM, Noble JH, et al. Insertion depth impacts speech perception and hearing preservation for lateral wall electrodes. Laryngoscope. 2017; Oct. 127(10):2352–7.

102. Chakravorti S, Noble JH, Gifford RH, Dawant BM, O’Connell BP, Wang J, et al. Further evidence of the relationship between cochlear implant electrode positioning and hearing outcomes. Otol Neurotol. 2019; Jun. 40(5):617–24.

103. Dhanasingh A, Jolly C. An overview of cochlear implant electrode array designs. Hear Res. 2017; Dec. 356:93–103.

104. Dhanasingh A. Cochlear duct length along the outer wall vs organ of corti: which one is relevant for the electrode array length selection and frequency mapping using Greenwood function. World J Otorhinolaryngol Head Neck Surg. 2018; Dec. 5(2):117–21.

105. Escude B, James C, Deguine O, Cochard N, Eter E, Fraysse B. The size of the cochlea and predictions of insertion depth angles for cochlear implant electrodes. Audiol Neurootol. 2006; 11 Suppl 1:27–33.

106. Zahara D, Dewi RD, Aboet A, Putranto FM, Lubis ND, Ashar T. Variations in cochlear size of cochlear implant candidates. Int Arch Otorhinolaryngol. 2019; Apr. 23(2):184–90.

107. Grover M, Sharma S, Singh SN, Kataria T, Lakhawat RS, Sharma MP. Measuring cochlear duct length in Asian population: worth giving a thought! Eur Arch Otorhinolaryngol. 2018; Mar. 275(3):725–8.